Tumours harness several strategies to avoid elimination by the immune system and exploiting the programmed cell death protein (PD1) is a key component. Studies have shown that the expression of PD1 by tumour-infiltrating lymphocytes is . . .
Sign Up or Log In as a healthcare professional to read the full article.